1,1'-Carbonyldiimidazole → HCID 53357308, Verbindung
Reaktionsgleichung
[OH:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6](=[O:26])[C:7]([C:16]3[CH:25]=[CH:24][C:19]([C:20]([NH:22][NH2:23])=[O:21])=[CH:18][CH:17]=3)=[C:8]([C:12]([F:15])([F:14])[F:13])[O:9]2)=[CH:4][CH:3]=1.C1N=CN([C:32](N2C=NC=C2)=[O:33])C=1>C(Cl)Cl>[OH:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6](=[O:26])[C:7]([C:16]3[CH:25]=[CH:24][C:19]([C:20]4[O:21][C:32](=[O:33])[NH:23][N:22]=4)=[CH:18][CH:17]=3)=[C:8]([C:12]([F:14])([F:15])[F:13])[O:9]2)=[CH:4][CH:3]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
4-(7-hydroxy-4-oxo-2-(trifluoromethyl)-4H-chromen-3-yl)benzohydrazide (1 equiv.) and CDI (10 equiv.) in DCM is refluxed overnight. An aqueous/EtOAc workup followed by purification by prep-HPLC can give the desired product in Example 23.
Aufarbeitung
- customAn aqueous/EtOAc workup followed by purification by prep-HPLC
Quellen und Nachweise
- ORD-Eintrag
- ord-0d92cb687d26480ba8e90299a36e2748
- Quelldatensatz
- uspto-grants-2015_11
- Patentnummer
- US09187447B2
Notizen zur Reaktion
Wird geladen…